体外毒性検査の世界市場2019-2023

LINEで送る

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY END-USER
• Market segmentation by end-user
• Comparison by end-user
• Pharmaceutical and biotechnology companies –
• Market size and forecast 2018-2023
• Academic and research institutions – Market size and forecast 2018-2023
• Others – Market size and forecast 2018-2023
• Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Advances in toxicology
• Surge in demand for cosmetics
• Increasing investments in drug discovery
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott Laboratories
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• CELTHER POLSKA Sp z o.o.
• Charles River Laboratories International Inc.
• Eurofins GSC Lux Sarl
• Evotec AG
• General Electric Co.
• Merck KGaA
• Thermo Fisher Scientific Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Product overview
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: End-user – Market share 2018-2023 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Pharmaceutical and biotechnology companies – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Pharmaceutical and biotechnology companies – Year-over-year growth 2019-2023 (%)
Exhibit 22: Academic and research institutions – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Academic and research institutions – Year-over-year growth 2019-2023 (%)
Exhibit 24: Others – Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Others – Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by end-user
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America – Year-over-year growth 2019-2023 (%)
Exhibit 32: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 34: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 36: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 37: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abbott Laboratories – Vendor overview
Exhibit 47: Abbott Laboratories – Business segments
Exhibit 48: Abbott Laboratories – Organizational developments
Exhibit 49: Abbott Laboratories – Geographic focus
Exhibit 50: Abbott Laboratories – Segment focus
Exhibit 51: Abbott Laboratories – Key offerings
Exhibit 52: Agilent Technologies Inc. – Vendor overview
Exhibit 53: Agilent Technologies Inc. – Business segments
Exhibit 54: Agilent Technologies Inc. – Organizational developments
Exhibit 55: Agilent Technologies Inc. – Geographic focus
Exhibit 56: Agilent Technologies Inc. – Segment focus
Exhibit 57: Agilent Technologies Inc. – Key offerings
Exhibit 58: Bio-Rad Laboratories Inc. – Vendor overview
Exhibit 59: Bio-Rad Laboratories Inc. – Business segments
Exhibit 60: Bio-Rad Laboratories Inc. – Organizational developments
Exhibit 61: Bio-Rad Laboratories Inc. – Geographic focus
Exhibit 62: Bio-Rad Laboratories Inc. – Segment focus
Exhibit 63: Bio-Rad Laboratories Inc. – Key offerings
Exhibit 64: CELTHER POLSKA Sp z o.o. – Vendor overview
Exhibit 65: CELTHER POLSKA Sp z o.o. – Business segments
Exhibit 66: CELTHER POLSKA Sp z o.o. – Organizational developments
Exhibit 67: CELTHER POLSKA Sp z o.o. – Key offerings
Exhibit 68: Charles River Laboratories International Inc. – Vendor overview
Exhibit 69: Charles River Laboratories International Inc. – Business segments
Exhibit 70: Charles River Laboratories International Inc. – Organizational developments
Exhibit 71: Charles River Laboratories International Inc. – Geographic focus
Exhibit 72: Charles River Laboratories International Inc. – Segment focus
Exhibit 73: Charles River Laboratories International Inc. – Key offerings
Exhibit 74: Eurofins GSC Lux Sarl – Vendor overview
Exhibit 75: Eurofins GSC Lux Sarl – Business segments
Exhibit 76: Eurofins GSC Lux Sarl – Organizational developments
Exhibit 77: Eurofins GSC Lux Sarl – Geographic focus
Exhibit 78: Eurofins GSC Lux Sarl – Segment focus
Exhibit 79: Eurofins GSC Lux Sarl – Key offerings
Exhibit 80: Evotec AG – Vendor overview
Exhibit 81: Evotec AG – Business segments
Exhibit 82: Evotec AG – Organizational developments
Exhibit 83: Evotec AG – Geographic focus
Exhibit 84: Evotec AG – Segment focus
Exhibit 85: Evotec AG – Key offerings
Exhibit 86: General Electric Co. – Vendor overview
Exhibit 87: General Electric Co. – Business segments
Exhibit 88: General Electric Co. – Organizational developments
Exhibit 89: General Electric Co. – Geographic focus
Exhibit 90: General Electric Co. – Segment focus
Exhibit 91: General Electric Co. – Key offerings
Exhibit 92: Merck KGaA – Vendor overview
Exhibit 93: Merck KGaA – Business segments
Exhibit 94: Merck KGaA – Organizational developments
Exhibit 95: Merck KGaA – Geographic focus
Exhibit 96: Merck KGaA – Segment focus
Exhibit 97: Merck KGaA – Key offerings
Exhibit 98: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 99: Thermo Fisher Scientific Inc. – Business segments
Exhibit 100: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 101: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 102: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 103: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 104: Validation techniques employed for market sizing
Exhibit 105: Definition of market positioning of vendors




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様